ANTX News
Official issuer or fund updates, exact SEC current reports, and large established publisher coverage, newest first. Every lawfully retained item remains in the corpus; each public page contains at most 100 rows. Headlines open the exact source; summaries are concise descriptions and not investment recommendations. Captured 2026-08-31.
| Date | Type | Publisher | Headline | Summary |
|---|---|---|---|---|
| 2026-08-11 | Current report | SEC filing | AN2 Therapeutics, Inc. filed Form 8-K | AN2 Therapeutics, Inc. filed Form 8-K covering items 2.02,9.01. |
| 2026-06-09 | Current report | SEC filing | AN2 Therapeutics, Inc. filed Form 8-K | AN2 Therapeutics, Inc. filed Form 8-K covering items 5.07. |
| 2026-06-04 | Current report | SEC filing | AN2 Therapeutics, Inc. filed Form 8-K | AN2 Therapeutics, Inc. filed Form 8-K covering items 7.01,8.01,9.01. |
| 2026-05-11 | Current report | SEC filing | AN2 Therapeutics, Inc. filed Form 8-K | AN2 Therapeutics, Inc. filed Form 8-K covering items 2.02,9.01. |
| 2026-04-09 | Current report | SEC filing | AN2 Therapeutics, Inc. filed Form 8-K | AN2 Therapeutics, Inc. filed Form 8-K covering items 8.01,9.01. |
| 2026-03-20 | Current report | SEC filing | AN2 Therapeutics, Inc. filed Form 8-K | AN2 Therapeutics, Inc. filed Form 8-K covering items 5.02. |
| 2026-03-17 | Current report | SEC filing | AN2 Therapeutics, Inc. filed Form 8-K | AN2 Therapeutics, Inc. filed Form 8-K covering items 2.02,9.01. |
| 2026-03-10 | Current report | SEC filing | AN2 Therapeutics, Inc. filed Form 8-K | AN2 Therapeutics, Inc. filed Form 8-K covering items 1.01,3.02,7.01,9.01. |
| 2026-01-29 | Current report | SEC filing | AN2 Therapeutics, Inc. filed Form 8-K | AN2 Therapeutics, Inc. filed Form 8-K covering items 5.02. |
| 2025-11-12 | Current report | SEC filing | AN2 Therapeutics, Inc. filed Form 8-K | AN2 Therapeutics, Inc. filed Form 8-K covering items 2.02,9.01. |
| 2025-08-12 | Current report | SEC filing | AN2 Therapeutics, Inc. filed Form 8-K | AN2 Therapeutics, Inc. filed Form 8-K covering items 9.01. |
| 2025-06-20 | Current report | SEC filing | AN2 Therapeutics, Inc. filed Form 8-K | AN2 Therapeutics, Inc. filed Form 8-K covering items 3.02,9.01. |
| 2025-06-11 | Current report | SEC filing | AN2 Therapeutics, Inc. filed Form 8-K | AN2 Therapeutics, Inc. filed Form 8-K covering items 7.01,9.01. |
| 2025-05-27 | Current report | SEC filing | AN2 Therapeutics, Inc. filed Form 8-K | AN2 Therapeutics, Inc. filed Form 8-K covering items 5.07. |
| 2025-05-13 | Current report | SEC filing | AN2 Therapeutics, Inc. filed Form 8-K | AN2 Therapeutics, Inc. filed Form 8-K covering items 9.01. |
| 2025-05-01 | Current report | SEC filing | AN2 Therapeutics, Inc. filed Form 8-K | AN2 Therapeutics, Inc. filed Form 8-K covering items 7.01,9.01. |
| 2025-03-25 | Current report | SEC filing | AN2 Therapeutics, Inc. filed Form 8-K | AN2 Therapeutics, Inc. filed Form 8-K covering items 2.02,9.01. |
| 2024-11-13 | Current report | SEC filing | AN2 Therapeutics, Inc. filed Form 8-K | AN2 Therapeutics, Inc. filed Form 8-K covering items 2.02,9.01. |
| 2024-11-05 | Current report | SEC filing | AN2 Therapeutics, Inc. filed Form 8-K | AN2 Therapeutics, Inc. filed Form 8-K covering items 5.02. |
| 2024-08-19 | Current report | SEC filing | AN2 Therapeutics, Inc. filed Form 8-K | AN2 Therapeutics, Inc. filed Form 8-K covering items 1.01,3.03,5.03,9.01. |
| 2024-08-13 | Current report | SEC filing | AN2 Therapeutics, Inc. filed Form 8-K | AN2 Therapeutics, Inc. filed Form 8-K covering items 2.02,9.01. |
| 2024-08-08 | Current report | SEC filing | AN2 Therapeutics, Inc. filed Form 8-K | AN2 Therapeutics, Inc. filed Form 8-K covering items 2.05,5.02,7.01,8.01,9.01. |
| 2024-06-24 | Current report | SEC filing | AN2 Therapeutics, Inc. filed Form 8-K | AN2 Therapeutics, Inc. filed Form 8-K covering items 5.07,9.01. |
| 2024-05-14 | Current report | SEC filing | AN2 Therapeutics, Inc. filed Form 8-K | AN2 Therapeutics, Inc. filed Form 8-K covering items 2.02,9.01. |
| 2024-03-28 | Current report | SEC filing | AN2 Therapeutics, Inc. filed Form 8-K | AN2 Therapeutics, Inc. filed Form 8-K covering items 2.02,9.01. |
| 2024-02-12 | Current report | SEC filing | AN2 Therapeutics, Inc. filed Form 8-K | AN2 Therapeutics, Inc. filed Form 8-K covering items 8.01. |
| 2023-11-09 | Current report | SEC filing | AN2 Therapeutics, Inc. filed Form 8-K | AN2 Therapeutics, Inc. filed Form 8-K covering items 2.02,9.01. |
| 2023-09-13 | Current report | SEC filing | AN2 Therapeutics, Inc. filed Form 8-K | AN2 Therapeutics, Inc. filed Form 8-K covering items 8.01,9.01. |
| 2023-09-08 | Current report | SEC filing | AN2 Therapeutics, Inc. filed Form 8-K | AN2 Therapeutics, Inc. filed Form 8-K covering items 5.02. |
| 2023-08-16 | Current report | SEC filing | AN2 Therapeutics, Inc. filed Form 8-K | AN2 Therapeutics, Inc. filed Form 8-K covering items 1.01,8.01,9.01. |
| 2023-08-10 | Current report | SEC filing | AN2 Therapeutics, Inc. filed Form 8-K | AN2 Therapeutics, Inc. filed Form 8-K covering items 2.02,9.01. |
| 2023-06-09 | Current report | SEC filing | AN2 Therapeutics, Inc. filed Form 8-K | AN2 Therapeutics, Inc. filed Form 8-K covering items 5.07. |
| 2023-05-11 | Current report | SEC filing | AN2 Therapeutics, Inc. filed Form 8-K | AN2 Therapeutics, Inc. filed Form 8-K covering items 2.02,9.01. |
| 2023-03-29 | Current report | SEC filing | AN2 Therapeutics, Inc. filed Form 8-K | AN2 Therapeutics, Inc. filed Form 8-K covering items 2.02,9.01. |
| 2022-11-09 | Current report | SEC filing | AN2 Therapeutics, Inc. filed Form 8-K | AN2 Therapeutics, Inc. filed Form 8-K covering items 2.02,9.01. |
| 2022-10-06 | Current report | SEC filing | AN2 Therapeutics, Inc. filed Form 8-K | AN2 Therapeutics, Inc. filed Form 8-K covering items 7.01,9.01. |
| 2022-08-11 | Current report | SEC filing | AN2 Therapeutics, Inc. filed Form 8-K | AN2 Therapeutics, Inc. filed Form 8-K covering items 2.02,9.01. |
| 2022-06-29 | Current report | SEC filing | AN2 Therapeutics, Inc. filed Form 8-K | AN2 Therapeutics, Inc. filed Form 8-K covering items 8.01,9.01. |
| 2022-05-10 | Current report | SEC filing | AN2 Therapeutics, Inc. filed Form 8-K | AN2 Therapeutics, Inc. filed Form 8-K covering items 2.02,9.01. |
| 2022-05-09 | Current report | SEC filing | AN2 Therapeutics, Inc. filed Form 8-K | AN2 Therapeutics, Inc. filed Form 8-K covering items 5.02,9.01. |